Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)
NCT05702437, Unknown, Istanbul University - Cerrahpasa
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome) | ClinicalTrials.gov |
| NCT number | NCT05702437 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Enrollment | 82 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Istanbul University - Cerrahpasa | ClinicalTrials.gov |
| Conditions | Metabolic Syndrome | ClinicalTrials.gov |
| Interventions | assessment of cognitive performance | ClinicalTrials.gov |
| First posted | 2023-01-27 | ClinicalTrials.gov |
| Last updated | 2024-01-12 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Evaluation of Metabolic Syndrome-waist circumference | once, at baseline | Waist Circumference measurement will be recorded with a tape measure in the middle between the last palpable rib and the upper edge of the iliac crest. | ClinicalTrials.gov |
| Primary | Evaluation of Metabolic Syndrome-blood pressure | once, at baseline | "Omron" digital blood pressure monitor will be used to measure systolic and diastolic blood pressure. Participants will be asked to rest for 5 minutes before the measurement. | ClinicalTrials.gov |
| Primary | Evaluation of Metabolic Syndrome-triglyceride | once, at baseline | Triglyceride, HDL-C and fasting plasma levels and biochemistry laboratory findings of individuals will be evaluated. Before the analysis, 8-12 hours of fasting is required so that it does not affect the test results. | ClinicalTrials.gov |
| Primary | Evaluation of Metabolic Syndrome-HDL-C | once, at baseline | Triglyceride, HDL-C and fasting plasma levels and biochemistry laboratory findings of individuals will be evaluated. Before the analysis, 8-12 hours of fasting is required so that it does not affect the test results. | ClinicalTrials.gov |
| Primary | Evaluation of Metabolic Syndrome-fasting plasma level | once, at baseline | Triglyceride, HDL-C and fasting plasma levels and biochemistry laboratory findings of individuals will be evaluated. Before the analysis, 8-12 hours of fasting is required so that it does not affect the test results. | ClinicalTrials.gov |
| Primary | Metabolic Syndrome Severity Score | once, at baseline | This scoring creates a z-score by considering factors such as age, race, gender, and metabolic syndrome components values. There is a website that automatically calculates the z-score when these data are entered. (https://metscalc.org/metscalc/) | ClinicalTrials.gov |
| Primary | Monreal Cognitive Assessment | once, at baseline | This scale consists of parts that evaluate executive functions, attention and concentration, memory, language, abstract thinking, visual-spatial skills, orientation and calculation. The application of MoCA takes about 10 minutes and the total score of the scale is calculated over 30 points. The threshold point value is 21. Scores of 20 or less are considered cognitive dysfunction. | ClinicalTrials.gov |
| Primary | Stroop Test TBAG Form | once, at baseline | a neuropsychological test that measures focused attention and the speed of information processing | ClinicalTrials.gov |
| Secondary | Mini Mental State Examination | once, at baseline | it is a test consisting of 11 questions that evaluate different cognitive parameters, including recording memory, attention and calculation, recall and language, motor function and perception. The maximum score that can be taken from the test is 30 and there is no time limit. In scoring, 24-30 points are normal, 23 points and below indicate mild cognitive impairment. | ClinicalTrials.gov |
| Secondary | Visual Reaction Test | once, at baseline | the participant sees a red circle appearing on a white screen on the computer at variable time intervals and should press the December key of the computer quickly as soon as he sees the circle. | ClinicalTrials.gov |
| Secondary | International Physical Activity Questionnare Short-Form | once, at baseline | taking into account the last week, the time spent on walking, moderate and vigorous activities is questioned. | ClinicalTrials.gov |
| Secondary | pedometer | once, at baseline | A valid and reliable method for comparing the participants' weekly step counts and determining their physical activity levels | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 5
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)